Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates Source Cluster: Fintech News Source Node: 1972660Time Stamp: May 9, 2024
Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization Source Cluster: ACN Newswire Source Node: 1961523Time Stamp: Apr 3, 2024
Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease to the U.S. FDA Source Cluster: JCN Newswire Source Node: 1961159Time Stamp: Mar 31, 2024
Can focused ultrasound provide a new way to manage pain? – Physics World Source Cluster: Physics World Source Node: 1952064Time Stamp: Feb 27, 2024